Proline-catalyzed diastereoselective direct aldol reaction between 4-oxoazetidine-2-carbaldehydes and ketones

Journal of Organic Chemistry

Volumn 71, Issue 13, 2006, Pages 4818-4822

  Alcaide, Benito ^a   Almendros, Pedro ^b   Luna, Amparo ^a   Torres, M Rosario ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOL; CARBALDEHYDES; DIASTEREOSELECTIVITIES; PROLINE;

ALDEHYDES; AMINO ACIDS; CATALYSIS; REACTION KINETICS; STEREOCHEMISTRY;

KETONES;

4 OXOAZETIDINE 2 CARBALDEHYDE; ALDEHYDE; GAMMA AMINO BETA HYDROXYKETONE; KETONE; PROLINE; UNCLASSIFIED DRUG;

ALDOL REACTION; ARTICLE; CATALYSIS; DIASTEREOISOMER; ENANTIOMER; QUANTUM YIELD; REACTION ANALYSIS; STEREOCHEMISTRY;

ALDEHYDES; AZETIDINES; CATALYSIS; KETONES; MOLECULAR CONFORMATION; PROLINE; STEREOISOMERISM;

EID: 33745492598     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0604235     Document Type: Article

References (64)

1. See. for example: (a) Niccolai, D.; Tarsi, L.; Thomas, R. J. Chem. Commun. 1997, 2333.
2. (b) Southgate, R. Contemp. Org. Synth. 1994, 1, 417.
3. (c) Southgate, R.; Branch, C.; Coulton, S.; Hunt, E. In Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbial Products; Lukacs, G., Ed.; Springer: Berlin, 1993; Vol. 2, p 621.
4. (d) The Chemistry of β-Lactams; Page, M. I., Ed.; Chapman and Hall: London, 1992A.
5. (e) Chemistry and Biology of β-Lactam Antibiotics; Morin, R. B., German, M., Eds.; Academic: New York, 1982; Vols. 1-3.
6. Some of the more notable advances concern the development of mechanism-based serine protease inhibitors of elastase, cytomegalovirus protease, thrombin, prostate-specific antigen, and cell metastasis and inhibitors of acyl-CoA cholesterol acyl transferase. For a review, see: (a) Veinberg, G.; Vorona, M.; Shestakova, I.; Kanepe, I.; Lukevics, E. Curr. Med. Chem. 2003, 10, 1741.
7. For selected examples, see: (b) Hogan, P. C.; Corey, E. J. J. Am. Chem. Soc. 2005, 127, 15386.
8. (c) Clader, J. W. J. Med. Chem. 2004, 47, 1.
9. (d) Kvaerno, L.; Ritter, T.; Werder, M.; Hauser, H.; Carreira, E. M. Angew. Chem., Int. Ed. 2004, 43, 4653.
10. (e) Burnett, D. A. Curr. Med. Chem. 2004, 11, 1873.
11. (f) Page, M. I.; Laws, A. P. Tetrahedron 2000, 56, 5631.
12. (g) Haley, T. M.; Angier, S. J.; Borthwick, A. D.; Singh, R.; Micetich, R. G. Drugs 2000, 3, 512.
13. (h) Bonneau, P. R.; Hasani, F.; Plouffe, C.; Malenfant, E.; LaPlante, S. R.; Guse, I.; Ogilvie, W. W.; Plante, R.; Davidson, W. C.; Hopkins, J. L.; Morelock, M. M.; Cordingley, M. G.; Deziel, R. J. Am. Chem. Soc. 1999, 121, 2965.
14. (i) Ogilvie, W. W.; Yoakim, C.; Do, F.; Hache, B.; Lagace, L.; Naud, J.; O'Meara, J. A.; Deziel, R. Bioorg. Med. Chem. Lett. 1999, 9, 1521.
15. (j) Vaccaro, W. D.; Davis, H. R., Jr. Bioorg. Med. Chem. Lett. 1998, 8, 313.
16. (k) Borthwick, A. D.; Weingarte, G.; Haley, T. M.; Tomaszewski, M.; Wang, W.; Hu, Z.; Bedard, J.; Jin, H.; Yuen, L.; Mansour, T. S. Bioorg. Med. Chem. Lett. 1998, 8, 365.
17. (l) Han, W. T.; Trehan, A. K.; Wright, J. J. K.; Federici, M. E.; Seiler, S. M.; Meanwell, N. A. Bioorg. Med. Chem. 1995, 3, 1123.
18. It has been reported that β-lactams act to modulate the expression of glutamate neurotransmitter transporters via gene activation. See: Rothstein, J. D.; Patel, S.; Regan, M. R.; Haenggeli, C.; Huang, Y. H.; Bergles, D. E.; Jin, L.; Hoberg, M. D.; Vidensky, S.; Chung, D. S.; Toan, S. V.; Bruijn, L. I.; Su, Z.-z.; Gupta, P.; Fisher, P. B. Nature 2005, 433, 73.
19. For selected reviews, see: (a) Alcaide, B.; Almendros, P. Curr. Med. Chem. 2004, 11, 1921.
20. (b) Deshmukh, A. R. A. S.; Bhawal, B. M.; Krishnaswamy, D.; Govande, V. V.; Shinkre, B. A.; Jayanthi, A. Curr. Med. Chem. 2004, 11, 1889.
21. (c) Alcaide, B.; Almendros, P. Synlett 2002, 381.
22. (d) Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Synlett 2001, 1813.
23. (e) Alcaide, B.; Almendros, P. Chem. Soc. Rev. 2001, 30, 226.
24. (f) Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Amino Acids 1999, 16, 321.
25. (g) Ojima, I.; Delaloge, F. Chem. Soc. Rev. 1997, 26, 377.
26. (h) Manhas, M. S.; Wagle, D. R.; Chiang, J.; Bose, A. K. Heterocycles 1988, 27, 1755.
27. See, for example: (a) Enders, D.; Reinhold, U. Angew. Chem., Int. Ed. Engl. 1995, 34, 1219.
28. (b) Rich, D. H. Peptidase Inhibitors. In Comprehensive Medicinal Chemistry; Sammes, P. G., Ed.; Pergamon Press: Oxford, 1990; Vol. 2, p 391.
29. (c) Huff, J. R. J. Med. Chem. 1991, 34, 2305.
30. (d) Thaisrivongs, S.; Pals, D. T.; Kroll, L. T.; Turner, S. R.; Han, F.-S. J. Med. Chem. 1987, 30, 976.
31. Reviews: (a) Modern Aldol Reactions; Mahrwald, R., Ed.; Wiley-VCH: Weinheim, 2004.
32. (b) Palomo, C.; Oiarbide, M.; García, J. M. Chem. Soc. Rev. 2004, 33, 65.
33. (c) Palomo, C.; Oiarbide, M.; García, J. M. Chem.-Eur. J. 2002, 8, 37.
34. (d) Machajewski, T. D.; Wong, C.-H. Angew. Chem., Int. Ed. 2000, 39, 1352.
35. For selected reviews, see: (a) List, B. Acc. Chem. Res. 2004, 37, 548.
36. (b) Notz, W.; Tanaka, F.; Barbas, C. F., III. Acc. Chem. Res. 2004, 37, 580.
37. (c) Alcaide B.; Almendros, P. Angew. Chem., Int. Ed. 2003, 42, 858.
38. (d) Jarvo, E. R.; Miller, S. J. Tetrahedron 2002, 55, 2481.
39. (e) List, B. Tetrahedron 2002, 58, 5573.
40. (f) Alcaide, B.; Almendros, P. Eur. J. Org. Chem. 2002, 1595.
41. (a) Alcaide, B.; Almendros, P.; Aragoncillo, C.; Redondo, M. C.; Torres, M. R. Chem.-Eur. J. 2006, 12, 1539.
42. (b) Alcaide, B.; Almendros, P.; Redondo, M. C.; Ruiz, M. P. J. Org. Chem. 2005, 70, 8890.
43. (c) Alcaide, B.; Almendros, P.; Rodríguez-Acebes, R. Chem.-Eur. J. 2005, 11, 5708.
44. (d) Alcaide, B.; Almendros, P.; Rodríguez-Acebes, R. J. Org. Chem. 2005, 70, 2713.
45. (e) Alcaide, B.; Almendros, P.; Cabrero, G.; Ruiz, M. P. Org. Lett. 2005, 7, 3981.
46. For reviews, see: (a) Gryko, D.; Chalko, J.; Jurczak, J. Chirality 2003, 15, 514.
47. (b) Reetz, M. T. Chem. Rev. 1999, 99, 1121.
48. (c) Reetz, M. T. Angew. Chem., Int. Ed. Engl. 1991, 30, 1531.
49. (d) Jurczak, J.; Golebiowski, A. Chem. Rev. 1989, 89, 149.
50. For recent selected reviews, see: (a) Tetrahedron 2006, 62, issues 2 and 3:
51. Organocatalysis in organic synthesis; Kočovský, P., Malkov, A. V., Guest Eds.
52. (b) Asymmetric Organocatalysis; Berkessel, A., Gröger, H., Eds.; Wiley-VCH: Weinheim, 2005.
53. (c) Seayad, J.; List, B. Org. Biomol. Chem. 2005, 3, 719-724.
54. (d) Dalko, P. I.; Moisan, D. L. Angew. Chem., Int. Ed. 2004, 43, 5138-5175.
55. (e) Johnson, J. S. Angew. Chem., Int. Ed. 2004, 43, 1326.
56. (f) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2001, 40, 3726.
57. The assignment of relative stereochemistry based on the observed coupling constant for methine protons H3 and H4 is a very well-established criterion in β-lactam chemistry. See, for example: (a) Alcaide, B.; Almendros, P.; Salgado, N. R.; Rodríguez-Vicente, A. J. Org. Chem. 2000, 65, 4453.
58. (b) Alcaide, B.; Aly, M. F.; Rodríguez, C.; Rodríguez- Vicente, A. J. Org. Chem. 2000, 65, 3453.
59. W) values were 4.06 (8.54) and 5.19 (13.30). CCDC-274849 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.can.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Centre, 12 Union Road, Cambridge CB21EZ, U.K.; fax (+44)1223-336033; or deposit@cccdc.cam.ac.uk).
60. W) values were 4.06 (8.54) and 5.19 (13.30). CCDC-274850 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.can.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Centre, 12 Union Road, Cambridge CB21EZ, U.K.; Fax (+44)1223-336033; or deposit@cccdc.cam.ac.uk).
61. (a) List, B. Chem. Commun. 2006, 819.
62. (b) Hoang, L.; Bahmanyar, S.; Houk, K. N.; List, B. J. Am. Chem. Soc. 2003, 125, 16.
63. Bahmanyar, S.; Houk, K. N.; Martin, H. J.; List, B. J. Am. Chem. Soc. 2003, 125, 2475.
64. Full spectroscopic and analytical data for compounds not included in this Experimental Section are described in the Supporting Information.